Clinical Trial Update: A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating stress heart imaging in patients with diabetes at risk for coronary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus

Drugs mentioned

• CARDIOLITE (TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE)

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Diabetes | Phase 4 | Status: COMPLETED